Understanding translational control mechanisms of the mTOR pathway in CHO cells by polysome profiling

N Biotechnol. 2014 Sep 25;31(5):514-23. doi: 10.1016/j.nbt.2013.10.003. Epub 2013 Oct 22.

Abstract

The mammalian target of rapamycin (mTOR) pathway plays essential roles in the regulation of translational activity in many eukaryotes. Thus, from a bioprocessing point of view, understanding its molecular mechanisms may provide potential avenues for improving cell culture performance. Toward this end, the mTOR pathway of CHO cells in batch cultures was subjected to rapamycin treatment (inhibition) or nutrient supplementation (induction) and translational activities of CHO cells producing a monoclonal antibody (mAb) were evaluated with polysome profiling technology. Expectedly, rapamycin induced a shift of mRNAs from polysomes towards monosomes, thus reducing maximum cellular growth rate by 30%, while feeding additional nutrients extended mTOR pathway activity during the stationary growth phase in control batch culture, thereby contributing to an increase in global translation activity by up to 2-fold, and up to 5-fold higher specific translation of the heavy and light chains of the recombinant mAb. These increases in translation activity correlated with a 5-day extension in cellular growth and a 4-fold higher final product titer observed upon nutrient feeding. This first study of the relationship between the mTOR pathway and translational activity in CHO cultures provides key insights into the role of translational control in supporting greater productivity, which will lead to further enhancement of CHO cultures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / biosynthesis*
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Immunosuppressive Agents / pharmacology*
  • Polyribosomes
  • Protein Biosynthesis / drug effects*
  • Recombinant Proteins / biosynthesis
  • Sirolimus / pharmacology*
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Recombinant Proteins
  • TOR Serine-Threonine Kinases
  • Sirolimus